Parabolic Drugs Q1 FY11 Results : Net up 36.22%

by khalid on 23/07/2010 · 0 comments

Parabolic Drugs engaged in the manufacturing, including contract manufacturing, of APIs and API intermediates for the domestic market as well as for exports to international markets. The company has announced Q1 (ending June 2010) results of the current fiscal (FY10-11) and the net profit rose 36.22% to Rs 10.53 crore. It was Rs 7.73 crore in Q1 (ending June 2009) last year.

The company informed the BSE that the total sales rose 22.06% to Rs 127.48 crore in Q1 (ending June 2010) of the current fiscal (FY10-11) when compared with the same quarter Q1 (ending June 2009) of previous year. Total sales was Rs 104.44 crores in last year’s quarter Q1.

Share’s Data :-
BSE Code : 533211
Mkt. Cap : Rs 370.47 Crores
Parabolic Drugs Ltd. share’s CMP is Rs 59.85 on 23rd July 2010.

Source :- BelltheBull

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: